A Study to Evaluate the Safety and Tolerability of Multiple Dose of STSP-0902 in Healthy Subjects

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 8, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions

Oligozoospermia

Interventions

DRUG

STSP-0902 injection

Subjects will receive the administration dose on Day 1 following protocol requirements

DRUG

Placebo

Subjects will receive the administration dose on Day 1 following protocol requirements

Trial Locations (1)

RECRUITING

Peking University Third Hospital, Beijing

All Listed Sponsors

lead

Staidson (Beijing) Biopharmaceuticals Co., Ltd

INDUSTRY